18F-fuorodeoxyglucose (FDG) positron emission tomography (PET) plays an important role in the staging and response assessment of lymphoma patients. Our aim was to explore the predictive relevance of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD16 trial. |